Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient-Reference-Cited by-同舟云学术

Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient

Published:2022-08 Issue:2 Volume:100 Page:243-244
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Tarantini Giuseppe¹^ORCID,Cardaioli Francesco¹

Affiliation:

1. Department of Cardiac, Thoracic, Vascular Sciences and Public Health University of Padua Medical School Padua Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.30333

Reference5 articles.

1. Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Vitamin K Antagonists or Direct Oral Anticoagulants

2. Continued Versus Interrupted Oral Anticoagulation During Transfemoral Transcatheter Aortic Valve Implantation and Impact of Postoperative Anticoagulant Management on Outcome in Patients With Atrial Fibrillation

3. RobertP AkodadM LattucaB et al.Transcatheter aortic valve implantation in patients with uninterrupted vitamin K antagonists.Catheter Cardiovasc Interv.2022;1‐8.doi:10.1002/ccd.30248

4. AndreottiF MassettiM tenBergJ.Defining optimal antithrombotic therapy post‐TAVI: the contribution of ATLANTIS.Eur Heart J.2022;ehac139.doi:10.1093/EURHEARTJ/EHAC139

5. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC working group on thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC council on valvular heart disease;Berg J;Eur Heart J,2021